טוען...
Minimal change disease with maximum immunosuppression: successful treatment of steroid-dependent minimal change disease with rituximab
Minimal change disease (MCD) is usually steroid sensitive, although in case of steroid dependent and multiple relapses we can struggle with different immunosuppressive agents, sometimes with no response. Rituximab has been emerging as an alternative therapeutic option. We describe a case of a young...
שמור ב:
| הוצא לאור ב: | BMJ Case Rep |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5836689/ https://ncbi.nlm.nih.gov/pubmed/29437743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-223407 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|